The SLC9A3R1 gene is associated with a rare genetic condition known as Nephrolithiasis-Osteoporosis, Hypophosphatemic Type 2. This condition is characterized by the development of kidney stones, reduced bone density leading to osteoporosis, and hypophosphatemia, which is an abnormally low level of phosphate in the blood. These symptoms result from mutations in the SLC9A3R1 gene, which plays a crucial role in phosphate regulation and bone mineralization.
To diagnose this condition, a specific genetic test is available at DNA Labs UAE. The test involves analyzing the patient's DNA to identify mutations in the SLC9A3R1 gene that are indicative of Nephrolithiasis-Osteoporosis, Hypophosphatemic Type 2. This genetic test is crucial for confirming the diagnosis, understanding the disease's progression, and guiding treatment and management strategies.
The cost of the SLC9A3R1 gene nephrolithiasis-osteoporosis hypophosphatemic type 2 genetic test at DNA Labs UAE is 4400 AED. Given the complexity and specificity of this test, it represents a critical step towards personalized medicine for patients exhibiting symptoms or having a family history of this rare condition. By identifying the genetic basis of the disease, healthcare providers can offer more targeted and effective interventions to manage and mitigate the symptoms associated with this disorder.
The NPHP1 Gene Nephronophthisis Type 1 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the NPHP1 gene. Nephronophthisis (NPHP) is a genetic disorder characterized by the inflammation and scarring of the kidneys, leading to a gradual loss of kidney function. Type 1 Nephronophthisis, the most common form of this condition, is directly associated with mutations in the NPHP1 gene.
This genetic test is critical for individuals showing symptoms of NPHP or those with a family history of the disease, as early detection can significantly influence management and treatment options. The test involves a detailed analysis of the patient's DNA to look for specific mutations in the NPHP1 gene that are known to cause the disease.
At DNA Labs UAE, the NPHP1 Gene Nephronophthisis Type 1 Genetic Test is priced at 4400 AED. This cost includes the collection of a DNA sample, usually through a blood draw or cheek swab, and its subsequent analysis in the laboratory. The result from this test can provide invaluable information for affected individuals and their families, including the confirmation of a NPHP diagnosis, information on the progression of the disease, and potential eligibility for targeted therapies or participation in clinical trials.
It's important for patients considering this test to consult with a healthcare professional or a genetic counselor to understand the implications of the results and to receive personalized advice based on their specific condition. DNA Labs UAE ensures confidentiality and accuracy in the testing process, providing a critical resource for individuals and families dealing with Nephronophthisis.
The TTC21B Gene Nephronophthisis Type 12 Genetic Test is a specialized diagnostic examination aimed at identifying mutations in the TTC21B gene, which are known to cause Nephronophthisis Type 12, a rare genetic disorder. This condition primarily affects the kidneys, leading to a gradual loss of kidney function, often resulting in kidney failure. Symptoms can include increased urine output, thirst, fatigue, and eventually, kidney failure requiring dialysis or transplantation. Early and accurate diagnosis through genetic testing is crucial for managing the disease effectively, allowing for appropriate treatment plans and genetic counseling for families.
The test is available at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the TTC21B gene. By opting for this test at DNA Labs UAE, individuals and families gain access to crucial information that can help in managing Nephronophthisis Type 12, planning for the future, and understanding the risk of recurrence in future generations.
The WDR19 gene nephronophthisis type 13 genetic test is a specialized diagnostic tool designed to identify mutations in the WDR19 gene, which are implicated in causing nephronophthisis type 13, a rare genetic disorder. Nephronophthisis is a form of kidney disease that primarily affects children and young adults, leading to chronic kidney failure. It is characterized by symptoms such as polyuria, polydipsia, anemia, and progression to end-stage renal disease.
This genetic test is crucial for early detection and management of the condition, allowing healthcare providers to tailor treatment plans according to the specific genetic mutation present. The test involves analyzing the patient's DNA to look for mutations in the WDR19 gene that are known to cause the disease. Early diagnosis through genetic testing can significantly impact the management of nephronophthisis, enabling interventions that can delay the progression of kidney damage.
The test is available at DNA Labs UAE, a leading facility in genetic testing and diagnostics. The cost of the WDR19 gene nephronophthisis type 13 genetic test is 4400 AED. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experts in genetic analysis, ensuring accurate and reliable results. Patients seeking this test are usually referred by their healthcare provider, and it requires a sample of blood or saliva for analysis. The outcome of the test not only helps in the diagnosis but also aids in family planning and the assessment of risk for siblings and other family members.
The ZNF423 gene plays a crucial role in the development and function of the kidneys. Mutations in the ZNF423 gene are associated with Nephronophthisis type 14, a rare genetic disorder characterized by kidney dysfunction, which often progresses to end-stage renal disease. This condition is part of a group of cystic kidney diseases and can present symptoms such as increased urine output, thirst, and fatigue, typically emerging in childhood or adolescence.
The genetic test for Nephronophthisis type 14, focused on identifying mutations in the ZNF423 gene, is a critical tool for diagnosing this condition. It allows for precise genetic counseling, informs treatment strategies, and helps in understanding the prognosis of the disease. Conducted at DNA Labs UAE, a facility known for its advanced genetic testing capabilities, this specific test costs 4400 AED. The test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed to detect the presence of mutations in the ZNF423 gene that are indicative of Nephronophthisis type 14. Early diagnosis through this genetic test can significantly impact the management of the disease and the quality of life of affected individuals and their families.
The "CEP164 Gene Nephronophthisis Type 15 Genetic Test" is a specialized diagnostic tool offered by DNA Labs UAE, aimed at identifying mutations in the CEP164 gene, which are linked to Nephronophthisis Type 15, a rare genetic disorder. This condition is part of a group of ciliopathies known for affecting the kidneys, leading to a spectrum of symptoms such as reduced kidney function, and in severe cases, kidney failure. Early detection through this test can be crucial for managing the disease's progression, allowing for tailored treatment plans and improved patient outcomes. The test is priced at 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the CEP164 gene. By opting for this test at DNA Labs UAE, individuals at risk or families with a history of the condition can gain valuable insights into their genetic makeup, enabling proactive health management and genetic counseling.
The ANKS6 gene nephronophthisis type 16 genetic test is a specialized diagnostic examination designed to identify mutations in the ANKS6 gene, which are associated with nephronophthisis type 16, a rare genetic disorder. This condition is part of a group of kidney diseases known as ciliopathies, characterized by their impact on the structure and function of cilia in the kidneys, leading to chronic kidney disease and potentially kidney failure.
Nephronophthisis type 16, specifically linked to anomalies in the ANKS6 gene, manifests through symptoms such as increased thirst and urination, fatigue, and in some cases, growth retardation and bone deformities due to the progressive loss of kidney function. Early and accurate diagnosis through genetic testing can be crucial for managing the condition, offering insights into the prognosis, and guiding treatment options.
The test is conducted at DNA Labs UAE, a facility renowned for its advanced genetic testing capabilities. The cost of the ANKS6 gene nephronophthisis type 16 genetic test is 4400 AED. This comprehensive testing process involves analyzing the patient's DNA to detect mutations in the ANKS6 gene, offering a valuable tool for families seeking answers about this inheritable condition. With the results, healthcare providers can tailor medical management plans to the individual's needs, potentially improving quality of life and outcomes for those affected by nephronophthisis type 16.
The "DCDC2 Gene Nephronophthisis Type 19 Genetic Test" is a specialized diagnostic examination designed to identify mutations in the DCDC2 gene, which is associated with Nephronophthisis Type 19, a rare genetic disorder. This condition is part of a group of ciliopathies known for affecting the kidneys, leading to a progressive loss of kidney function, and potentially resulting in kidney failure. Symptoms can vary but often include polyuria, polydipsia, and secondary enuresis, reflecting the impaired concentrating ability of the kidneys.
The test is crucial for early detection, enabling healthcare providers to devise an appropriate management plan for affected individuals. It involves analyzing the patient's DNA to look for specific genetic alterations in the DCDC2 gene that are known to cause the disorder. Early diagnosis through this test can significantly impact the treatment and management of the condition, potentially improving the quality of life for those affected.
This genetic test is available at DNA Labs UAE, a leading facility specializing in a wide array of genetic analyses. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the DCDC2 gene. By opting for this test at DNA Labs UAE, patients can expect reliable results, contributing to better-informed decisions regarding their health and management of Nephronophthisis Type 19.
The "INVS Gene Nephronophthisis Type 2 Genetic Test" is a specialized diagnostic examination performed to detect mutations in the INVS gene, which are associated with Nephronophthisis Type 2, a rare genetic disorder. This condition is characterized by the progressive loss of kidney function, leading to end-stage renal disease. The test is particularly vital for individuals with a family history of the disease or those exhibiting symptoms, as early detection can significantly impact management and treatment options.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed for specific genetic alterations in the INVS gene. The process is highly accurate and provides crucial information for the diagnosis, prognosis, and potential treatment plans for affected individuals.
The cost of the INVS Gene Nephronophthisis Type 2 Genetic Test at DNA Labs UAE is set at 4400 AED. This investment covers the comprehensive analysis and detailed reporting necessary to understand the genetic basis of the condition, offering a crucial step towards personalized medical care for patients with this rare kidney disorder.
The NPHP3 gene nephronophthisis type 3 genetic test is a specialized diagnostic procedure designed to identify mutations in the NPHP3 gene, which are implicated in causing nephronophthisis type 3, a rare genetic disorder. Nephronophthisis is a form of kidney disease that primarily affects children and young adults, leading to chronic kidney failure. The disease is characterized by inflammation and scarring (fibrosis) in the kidneys.
This genetic test is crucial for the accurate diagnosis of nephronophthisis type 3, enabling healthcare providers to tailor treatment plans effectively and offer genetic counseling to families. The test involves analyzing the patient's DNA to look for specific mutations in the NPHP3 gene that are known to cause the disorder.
Performed at DNA Labs UAE, a reputable facility known for its advanced genetic testing capabilities, the test ensures high accuracy and reliability. The cost of the NPHP3 gene nephronophthisis type 3 genetic test is 4400 AED, reflecting the comprehensive analysis and expertise required to conduct this specialized diagnostic procedure. By opting for this test, patients and their families can gain valuable insights into the genetic basis of nephronophthisis type 3, facilitating better management of the condition and informed decision-making regarding family planning.
